Home » MDS to Commercialize Signature BioScience s Proteomics Technology

MDS to Commercialize Signature BioScience s Proteomics Technology

Aug 16, 2001

NEW YORK, Aug 16 – Canadian life science company MDS has agreed to develop and commercialize Signature BioScience's microwave spectroscopy instrumentation, the companies announced.

MDS will pay Signature Biosciences $10 million upfront and will provide additional milestone and royalty payments in exchange for exclusive license rights to commercialize the microwave spectroscopy instrumentation and peripherals. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Cells of Something Else

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

SCID Treatment Funded in UK

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Call to Undo Brazilian Cuts

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

This Week in PLOS

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.